Literature DB >> 20151348

Management of refractory breathlessness in patients with advanced cancer.

Steffen T Simon1, Claudia Bausewein.   

Abstract

Breathlessness is a common and distressing symptom in advanced cancer. Management comprises non-pharmacological and pharmacological interventions, which are best combined. There is some evidence mainly derived from COPD studies for walking aids, neuro-muscular electrical stimulation, fan and breathlessness services. Opioids are the drugs of choice for pharmacological management of breathlessness. There is currently not enough evidence to support the routine use of benzodiazepines, other anxiolytics, antidepressants, phenothiazines, inhaled furosemide and oxygen.

Entities:  

Mesh：

Year:  2009        PMID： 20151348     DOI： 10.1007/s10354-009-0728-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  50 in total

1.  Effect of rollator use on health-related quality of life in individuals with COPD.

Authors:  Renu B Gupta; Dina Brooks; Yves Lacasse; Roger S Goldstein
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

Review 2.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

3.  Mechanisms of improvement in exercise capacity using a rollator in patients with COPD.

Authors:  Vanessa S Probst; Thierry Troosters; Iris Coosemans; Martijn A Spruit; Fabio de Oliveira Pitta; Marc Decramer; Rik Gosselink
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

4.  The use of chlorpromazine for symptom control in dying cancer patients.

Authors:  B McIver; D Walsh; K Nelson
Journal:  J Pain Symptom Manage       Date:  1994-07       Impact factor: 3.612

Review 5.  Nonpharmacological management of dyspnea.

Authors:  Gary T Buckholz; Charles F von Gunten
Journal:  Curr Opin Support Palliat Care       Date:  2009-06       Impact factor: 2.302

6.  The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease.

Authors:  H P Liss; B J Grant
Journal:  Am Rev Respir Dis       Date:  1988-06

7.  The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD.

Authors:  Sherra Solway; Dina Brooks; Louis Lau; Roger Goldstein
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

Review 8.  Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.

Authors:  Saskie Dorman; Anthony Byrne; Adrian Edwards
Journal:  Palliat Med       Date:  2007-03-15       Impact factor: 4.762

9.  Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.

Authors:  T Eaton; J E Garrett; P Young; W Fergusson; J Kolbe; S Rudkin; K Whyte
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

10.  The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Authors:  Morag C Farquhar; Irene J Higginson; Petrea Fagan; Sara Booth
Journal:  BMC Palliat Care       Date:  2009-07-07       Impact factor: 3.234
View more
  2 in total

1.  Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany.

Authors:  Sebastian Frechen; Anna Zoeller; Klaus Ruberg; Raymond Voltz; Jan Gaertner
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

2.  Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna.

Authors:  Gudrun Pohl; Christine Marosi; Karin Dieckmann; Gregor Goldner; Katarzyna Elandt; Marco Hassler; Michael Schemper; Kathrin Strasser-Weippl; Friedemann Nauck; Jan Gaertner; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.